|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market Outlook to 2015: Implementing innovative, long-term strategies for sustainable future growth
Business Insights, May 2005, Pages: 131
The Pharmaceutical Market Outlook to 2015: Implementing innovative, long-term strategies for sustainable future growth, examines the key changes in market strategy which will help companies to boost profitability, drive market share and enhance R&D productivity. This report also provides insight into the drivers and resistors of the pharmaceutical market to 2015, with a unique survey of 300 senior industry executives from pharmaceutical, biotech, speciality and generics sectors.
Growth in the pharmaceutical industry is currently driven by innovation in biotechnology, the increasing aging population, and emerging geographical markets such as China and India. Pharmaceutical companies are increasingly collaborating with biotech companies to leverage their expertise, products and operations to help overcome the productivity gap and promote future growth.
Use this report to benchmark the networking growth model used by your competitors, identify potential alliance partners and plan a long-term growth strategy to secure your leading position in the next ten years.
Key findings of the report:
- Despite the challenge of operating in China, it is the fastest growing pharmaceutical market, rising by 28% in 2004, versus 7% global growth. It is currently the ninth largest pharmaceutical market but at current growth rates China is likely to overtake Germany and France by 2015.
- The greatest threats to maximizing sales and marketing effectiveness are generic competition and price containment.
- Biotech is currently the fastest growing sector in the drug industry and is forecast to record sales of $250bn by 2015 (20.3% of the global market). The US biotech market grew at a rate almost twice that of the overall drug market for the second year running in 2004.
- 91% of industry executives believe pharma-biotech mergers will increase in the next 10 years, and 69% also believed there was likely to be increased consolidation between companies within the biotech sector.
- By 2015 big pharmaceutical companies will focus more on its core competencies of sales and marketing, supported by a networked R&D organization consisting of mulitple long-term relationships with biotechs.
Key questions answered in this report:
- Which sectors of the pharmaceutical market are forecast to show the strongest growth to 2015?
- Which disease areas and patient groups represent the best growth opportunities for pharmaceutical companies?
- What is the best strategy for pharmaceutical companies looking to move into the biotech sector?
- Which pharmaceutical companies have successfully moved into the generics market, and what was the key to this success?
- Which industry sectors are forecast to see a significant increase in alliance activity?
- What type of growth and alliance strategies are the leading players using?
- Why do pharmaceutical companies need to favor long-term strategies over short-term solutions to overcome the R&D productivity crisis?
Top five reasons to read this report today:
- Examine the growth potential in the pharmaceutical, biotech, speciality and generic industry sectors to 2015 with an exclusive industry opinion survey of 300 senior industry executives.
- Analyze how innovative companies such as Pfizer, GSK, Sanofi-Aventis, Novartis, Roche and UCB are positioning themselves for future growth in terms of geographic expansion and therapeutic focus, investment in biotech or generics, and the creation of networked pharmaceutical companies.
- Identify the critical success factors for pharmaceutical companies moving into the biotech and generics markets, through detailed case studies and analysis of past winners and losers.
- Address the issue of poor R&D productivity by understanding how to effectively restructure your internal R&D organization and establish a network of alliances and partnerships for external sources of innovation.
- Build new and profitable relationships with key customers and generate strong sales growth by understanding how to target growing patient populations.
Customers who bought this item also bought
The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology
Pharmaceutical Research and Development (R&D) - Increasing Efficiency through Information Technology and Externalization
State of the Pharmaceutical Industry, 2010 - Critical Role of Midsize Pharma
Will Big Pharma Find Success in Generics?
SPECIAL REPORT: Lessons Learned in the Pharma Industry, 2008
Special Report: Successes and Lessons Learned in the Pharmaceutical Industry, 2009
Successful Pharmabiotech Alliance Strategies: Driving Synergies, Avoiding Failure and Managing Relationships
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
China: The Key Pharmemerging Market - Deciphering Major Pharma Companies’ China Strategy
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
|
|
|
|
